Results 231 to 240 of about 66,618 (347)
Umbilical cord bilirubin as a predictor of neonatal jaundice: a retrospective cohort study [PDF]
A Knudsen+19 more
core +1 more source
CRB‐2131, as a novel Nox inhibitor, suppresses brain oxidation, tauopathy, and neuro‐inflammation, thereby preventing death of mature neurons and promoting regeneration of immature neurons. Ultimately, this fosters a resilient brain and protects cognition.
Jihyeon Lee+13 more
wiley +1 more source
Immunoglobulin G dynamics and outcomes of hypogammaglobulinemia in liver transplant recipients. [PDF]
Lee Y+8 more
europepmc +1 more source
Ovarian cancer patients with high levels of mortalin protein in their tumors have worse survival. The investigational drug SHetA2 interferes with mortalin's support of mitochondria. The resulting mitochondrial damage causes a process called mitophagy that contributes to how SHetA2 kills cancer cells. Noncancerous cells repair their mitochondria through
Vishal Chandra+9 more
wiley +1 more source
Early Prediction of ABO HDN Using Immuno-Hematological and Biochemical Tests. [PDF]
Patale D, Sharma J, Modi C, Bhagwat S.
europepmc +1 more source
EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy
This review provides new perspectives on EGFR's activation, mutations, and their impact on tumor immunotherapy. It summarizes how EGFR is activated and the current EGFR targeting strategy, evaluates their clinical outcomes in combination with immunotherapy, highlighting differential responses in tumors with EGFR wild‐type and different mutants.
Yuanzhuo Gu+7 more
wiley +1 more source
The facultative intracellular symbiont <i>Lariskella</i> is neutral for lifetime fitness and spreads through cytoplasmic incompatibility in the leaffooted bug, <i>Leptoglossus zonatus</i>. [PDF]
Umanzor EF+4 more
europepmc +1 more source
From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies
This review discusses emerging paradigms in CAR‐T cell therapy for solid tumors, emphasizing strategies to overcome therapeutic barriers through synthetic biology, immune engineering, and combinatorial approaches. It highlights advancements in logic gating, modulation of the immune microenvironment, and innovative cell designs, providing valuable ...
Yang Chen+7 more
wiley +1 more source
First ABO-Incompatible Pediatric Kidney Transplant in South Africa-A Case Report. [PDF]
Coetzee A+9 more
europepmc +1 more source